Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Sofia Cutaia"'
Autor:
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Mariano Catello Di Donna, Ugo Randazzo, Clarissa Filorizzo, Chiara Lisanti, Luigi Magrin, Vittorio Gurrera, Raffaella Romano, Alessandra Dimino, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Antonio Giordano, Vito Chiantera, Antonio Russo, Viviana Bazan, Juan Lucio Iovanna
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background The most common subtype of ovarian cancer (OC) showing immunogenic potential is represented by the high-grade serous ovarian cancer (HGSOC), which is characterized by the presence of tumor-infiltrating immune cells able to modulat
Externí odkaz:
https://doaj.org/article/dfb910f19c8541319a410ae55d310035
Autor:
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Sofia Cutaia, Mariano Catello Di Donna, Clarissa Filorizzo, Maria Chiara Lisanti, Ugo Randazzo, Luigi Magrin, Raffaella Romano, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Vito Chiantera, Antonio Russo, Viviana Bazan, Juan Lucio Iovanna
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The most common subtype of ovarian cancer (OC) is the high-grade serous ovarian carcinoma (HGSOC), accounting for 70%–80% of all OC deaths. Although HGSOC is a potentially immunogenic tumor, clinical studies assessing the effectiveness of inhibitor
Externí odkaz:
https://doaj.org/article/c26e4c93055a4acdb59f8734e5f341e3
Autor:
Antonio Galvano, Luisa Castellana, Valerio Gristina, Maria La Mantia, Lavinia Insalaco, Nadia Barraco, Alessandro Perez, Sofia Cutaia, Valentina Calò, Tancredi Didier Bazan Russo, Edoardo Francini, Lorena Incorvaia, Mario Giuseppe Mirisola, Salvatore Vieni, Christian Rolfo, Viviana Bazan, Antonio Russo
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The circulating tumor DNA (ctDNA) diagnostic accuracy for detecting phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha ( PIK3CA ) mutations in breast cancer (BC) is under discussion. We aimed to compare plasma and tiss
Externí odkaz:
https://doaj.org/article/aba0ba9293a840588bba5afa3b8c5075
Autor:
Valerio Gristina, Maria La Mantia, Antonio Galvano, Sofia Cutaia, Nadia Barraco, Marta Castiglia, Alessandro Perez, Marco Bono, Federica Iacono, Martina Greco, Katia Calcara, Valentina Calò, Sergio Rizzo, Lorena Incorvaia, Maria Chiara Lisanti, Giulia Santanelli, Delia Sardo, Sara Inguglia, Lavinia Insalaco, Luisa Castellana, Stefania Cusenza, Gianni Pantuso, Antonio Russo, Viviana Bazan
Publikováno v:
Journal of Molecular Pathology, Vol 2, Iss 2, Pp 173-196 (2021)
The molecular pathways which promote lung cancer cell features have been broadly explored, leading to significant improvement in prognostic and diagnostic strategies. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have dram
Externí odkaz:
https://doaj.org/article/073f09f41eb9496ab2daf6aa9c99d7c2
Autor:
Valerio Gristina, Nadia Barraco, Maria La Mantia, Luisa Castellana, Lavinia Insalaco, Marco Bono, Alessandro Perez, Delia Sardo, Sara Inguglia, Federica Iacono, Sofia Cutaia, Tancredi Didier Bazan Russo, Edoardo Francini, Lorena Incorvaia, Giuseppe Badalamenti, Antonio Russo, Antonio Galvano, Viviana Bazan
Publikováno v:
Cancers, Vol 14, Iss 23, p 6013 (2022)
Background: Despite the increasing implementation of targeted and immunotherapy-based treatments, the prognosis of patients with advanced NSCLC remains dismal. We prospectively evaluated longitudinal plasma cfDNA kinetics as an early marker of therap
Externí odkaz:
https://doaj.org/article/0309dedf1716498dac955d6c1d6a5a1e
Autor:
Lorena Incorvaia, Daniele Fanale, Marco Bono, Valentina Calò, Alessia Fiorino, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Daniela Cancelliere, Alessia Pivetti, Clarissa Filorizzo, Maria La Mantia, Nadia Barraco, Stefania Cusenza, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Several available data suggest the association between specific molecular subtypes and BRCA1/2 mutational status. Previous investigations showed the association between BRCA1/2 pathogenic variants (PVs) in specific genomic regions and phe
Externí odkaz:
https://doaj.org/article/e9cbd3a4ec0b4189919afc2b36594623
Autor:
Antonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, Lorena Incorvaia, Sergio Rizzo, Luisa Castellana, Stefania Cusenza, Sofia Cutaia, Daniele Santini, Fiorella Guadagni, Mario Roselli, Stefania Gori, Mario Adelfio Latteri, Viviana Bazan, Letizia Mauro Giulia, Antonio Russo
Publikováno v:
Journal of Bone Oncology, Vol 18, Iss , Pp - (2019)
Hormonal therapies for receptor positive-breast and prostate cancer patients have shown clinical efficacy but also several side effects including osteoporosis, loss of bone mass and increased fracture risk. Denosumab represents an anti RANKL (recepto
Externí odkaz:
https://doaj.org/article/161c435a51914811ab0735ace62178c6
Autor:
Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Marco Bono, Valentina Calò, Daniela Cancelliere, Marta Castiglia, Alessia Fiorino, Alessia Pivetti, Nadia Barraco, Sofia Cutaia, Antonio Russo, Viviana Bazan
Publikováno v:
Cancers, Vol 12, Iss 5, p 1158 (2020)
Recent advances in the detection of germline pathogenic variants (PVs) in BRCA1/2 genes have allowed a deeper understanding of the BRCA-related cancer risk. Several studies showed a significant heterogeneity in the prevalence of PVs across different
Externí odkaz:
https://doaj.org/article/9b8a946a5b844bbb9f0f9d775774c09c
Autor:
Antonio Galvano, Lorena Incorvaia, Giuseppe Badalamenti, Sergio Rizzo, Aurelia Guarini, Stefania Cusenza, Luisa Castellana, Nadia Barraco, Valentina Calò, Sofia Cutaia, Giuseppe Currò, Nicola Silvestris, Giordano Domenico Beretta, Viviana Bazan, Antonio Russo
Publikováno v:
Cancers, Vol 11, Iss 8, p 1189 (2019)
Monoclonal antibodies targeting epidermal growth factor receptor (EGFR) or vascular endothelial growth factor (VEGF) have demonstrated efficacy with chemotherapy (CT) as second line treatment for metastatic colorectal cancer (mCRC). The right sequenc
Externí odkaz:
https://doaj.org/article/b2f9e85885f349c99f5c423db9b23501
Autor:
Antonio Galvano, Luisa Castellana, Valerio Gristina, Maria La Mantia, Lavinia Insalaco, Nadia Barraco, Alessandro Perez, Sofia Cutaia, Valentina Calò, Tancredi Didier Bazan Russo, Edoardo Francini, Lorena Incorvaia, Mario Giuseppe Mirisola, Salvatore Vieni, Christian Rolfo, Viviana Bazan, Antonio Russo
Background: The circulating tumor DNA (ctDNA) diagnostic accuracy for detecting phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha ( PIK3CA) mutations in breast cancer (BC) is under discussion. We aimed to compare plasma and tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd8aa5e7a433475661184d1cbe7d40cf
http://hdl.handle.net/10447/570888
http://hdl.handle.net/10447/570888